Date: Apr 20, 2016 12:30 PM - 01:30 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Apr 20, 2016 10:00 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacist
Accreditation(s)
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
CPE Monitor: Requirement to Track your CPE
Important new requirement from the Accreditation Council for Pharmacy Education and the National Association of Boards of Pharmacy for all pharmacists and technicians who obtain CPE credit. The CPE Monitor system will securely track all your completed CPE credits in a central system.
Registration closes on Apr 20, 2016
at 10:00 PM
Registration closes on Apr 20, 2016
at 10:00 PM
Registration Closed
Registration Closed
Objectives
- Demonstrate an understanding of current Hepatitis C drug regimen efficacy and safety outcomes compare to previous interferon-based regimens.
- Define specific factors and parameters to be considered prior initiation of hepatitis C treatment and choice of a regimen.
- Recognize the challenges and monitoring parameters when treating a unique patient population of HCV Infected patients (renal failure, HIV/HCV co-infected, decompensated cirrhotic, or transplant patients).
Speaker(s)/Author(s)
|
Pierre Ndje, Pharm.D., Pharm.D.
|
Activity Number
0010-0000-16-001-L01-P
Date:
04/20/16
Time:
12:30 PM - 01:30 PM
CE Hours
1.00
Location
Howard University College of Pharmacy
Registration Closed